Here's Why Viatris Stock Is Sliding on Monday
28/2 19:07
What happened Shares of Viatris (NASDAQ: VTRS), the biopharmaceutical company behind the Epi-Pen and Lipitor, are falling in response to the company's fourth-quarter earnings call. The drugmaker's outlook for 2022 isn't as enthusiastic as analysts were expecting. Disappointed inv...